11.01.2024 • News

Nouryon Completes US Site Capacity Expansion for Colloidal Silica

Nouryon has completed a production capacity expansion of nearly 50% for its Levasil colloidal silica products at its US manufacturing facility in Green Bay, Wisconsin.

"Growing demand for Levasil colloidal silica, particularly in North America, is the driver of the expansion at our production facility," said Patrick Wilhelm, vice president Inorganic Specialties at Nouryon. “New factories for batteries, electric vehicles, and semiconductors in artificial intelligence applications are driving the rising customer demand. This latest capacity increase will enable us to serve global customers with our high-quality solutions,” Wilhelm added.

According to Nouryon, its Levasil colloidal silica are derived from two natural ingredients – sand and water – and serve a variety of end-markets. They are used as an abrasive in electronics applications for shaping, smoothing, and polishing silicon, metals, sapphire, and other precision substrate materials. In building and construction applications, they are used by admixture companies to increase the durability and strength in concrete.

The Dutch specialty chemicals producer operates eight Levasil production facilities worldwide.

© Nouryon
© Nouryon

Company

Logo:

Nouryon

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read